Literature DB >> 9368100

Molecular characterization of the murine Hif-1 alpha locus.

G Luo1, Y Z Gu, S Jain, W K Chan, K M Carr, J B Hogenesch, C A Bradfield.   

Abstract

Hypoxia inducible factor 1 alpha (HIF-1 alpha) is a basic helix-loop-helix-PAS (bHLH-PAS) transcription factor that mediates certain cellular responses to low oxygen tension, iron chelators, Co2+, Ni2+, Mg2+, and low intracellular glucose concentration. Upon exposure to the above conditions, HIF-1 alpha is upregulated and heterodimerizes with the Ah receptor nuclear translocator (ARNT, also known as HIF-1 beta), the heterodimeric complex binds TACGTG-containing genomic enhancer elements, and activates transcription of target genes. As a first step in developing genetic models to study the biology related to cellular hypoxia, we have cloned the murine HIF-1 alpha cDNA, determined the tissue-specific expression of its mRNA, functionally analyzed its protein product, and characterized its promoter and its genomic structure. A comparison between the murine and human HIF-1 alpha protein sequence reveals 95%, 99%, and 83% identity in the bHLH, PAS, and variable domains, respectively. RNAse protection assays demonstrate that in adult mice, the mHIF-1 alpha mRNA is expressed at high levels in kidney, heart, brain, thymus, and placenta, with moderate expression in liver, spleen, testis, and lung and much lower expression in skeletal muscle testis. Northern blot analysis indicates that the mRNA of the murine HIF-1 alpha is transcribed in two forms, a major 4-kb species and a minor 5-kb species; both are present in all tissues examined. The Hif-1 alpha promoter is GC rich, does not have a TATA element near its transcriptional start site, and does not respond to hypoxia or Co2+. The mHIF-1 alpha structural gene is composed of 15 exons. The splice junction sites within the bHLH and the PAS domains of HIF-1 alpha gene are highly conserved with respect to a number of previously characterized members of the bHLH-PAS superfamily. However, unlike other bHLH-PAS genes, where the variable domain is encoded by 2 exons, the variable region of the mHIF-1 alpha gene is encoded by 7 exons. Furthermore, most of these splice junction sites in the variable region are conserved with that of HIF-2 alpha, a recently cloned hypoxia-responsive bHLH-PAS protein (also known as MOP2, EPAS1, and HLF). These data suggest that HIF-1 alpha, along with HIF-2 alpha, represents a new subclass of the bHLH-PAS superfamily.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9368100      PMCID: PMC6148284     

Source DB:  PubMed          Journal:  Gene Expr        ISSN: 1052-2166


  39 in total

1.  The single-minded gene of Drosophila is required for the expression of genes important for the development of CNS midline cells.

Authors:  J R Nambu; R G Franks; S Hu; S T Crews
Journal:  Cell       Date:  1990-10-05       Impact factor: 41.582

2.  Characterization of a murine Ahr null allele: involvement of the Ah receptor in hepatic growth and development.

Authors:  J V Schmidt; G H Su; J K Reddy; M C Simon; C A Bradfield
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

3.  Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT.

Authors:  E Maltepe; J V Schmidt; D Baunoch; C A Bradfield; M C Simon
Journal:  Nature       Date:  1997-03-27       Impact factor: 49.962

4.  Characterization of a subset of the basic-helix-loop-helix-PAS superfamily that interacts with components of the dioxin signaling pathway.

Authors:  J B Hogenesch; W K Chan; V H Jackiw; R C Brown; Y Z Gu; M Pray-Grant; G H Perdew; C A Bradfield
Journal:  J Biol Chem       Date:  1997-03-28       Impact factor: 5.157

5.  PAS is a dimerization domain common to Drosophila period and several transcription factors.

Authors:  Z J Huang; I Edery; M Rosbash
Journal:  Nature       Date:  1993-07-15       Impact factor: 49.962

6.  In vitro analysis of Ah receptor domains involved in ligand-activated DNA recognition.

Authors:  K M Dolwick; H I Swanson; C A Bradfield
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

7.  Cloning of a factor required for activity of the Ah (dioxin) receptor.

Authors:  E C Hoffman; H Reyes; F F Chu; F Sander; L H Conley; B A Brooks; O Hankinson
Journal:  Science       Date:  1991-05-17       Impact factor: 47.728

8.  Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor.

Authors:  P Fernandez-Salguero; T Pineau; D M Hilbert; T McPhail; S S Lee; S Kimura; D W Nebert; S Rudikoff; J M Ward; F J Gonzalez
Journal:  Science       Date:  1995-05-05       Impact factor: 47.728

9.  Tissue specific expression of the rat Ah-receptor and ARNT mRNAs.

Authors:  L A Carver; J B Hogenesch; C A Bradfield
Journal:  Nucleic Acids Res       Date:  1994-08-11       Impact factor: 16.971

10.  Identification of functional domains of the aryl hydrocarbon receptor.

Authors:  B N Fukunaga; M R Probst; S Reisz-Porszasz; O Hankinson
Journal:  J Biol Chem       Date:  1995-12-08       Impact factor: 5.157

View more
  10 in total

1.  A dominant-negative isoform lacking exons 11 and 12 of the human hypoxia-inducible factor-1alpha gene.

Authors:  Yang-Sook Chun; Eunjoo Choi; Tae-You Kim; Myung-Suk Kim; Jong-Wan Park
Journal:  Biochem J       Date:  2002-02-15       Impact factor: 3.857

2.  The basic-helix-loop-helix-PAS orphan MOP3 forms transcriptionally active complexes with circadian and hypoxia factors.

Authors:  J B Hogenesch; Y Z Gu; S Jain; C A Bradfield
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

Review 3.  The transcriptional factors HIF-1 and HIF-2 and their novel inhibitors in cancer therapy.

Authors:  Najah Albadari; Shanshan Deng; Wei Li
Journal:  Expert Opin Drug Discov       Date:  2019-05-09       Impact factor: 6.098

4.  Hif1α down-regulation is associated with transposition of great arteries in mice treated with a retinoic acid antagonist.

Authors:  Francesca Amati; Laura Diano; Luisa Campagnolo; Lucia Vecchione; Daria Cipollone; Susana Bueno; Gianluca Prosperini; Alessandro Desideri; Gregorio Siracusa; Giovanni Chillemi; Bruno Marino; Giuseppe Novelli
Journal:  BMC Genomics       Date:  2010-09-16       Impact factor: 3.969

5.  Molecular characterization and chromosomal localization of a third alpha-class hypoxia inducible factor subunit, HIF3alpha.

Authors:  Y Z Gu; S M Moran; J B Hogenesch; L Wartman; C A Bradfield
Journal:  Gene Expr       Date:  1998

Review 6.  Targeting vasculature in urologic tumors: mechanistic and therapeutic significance.

Authors:  Shinichi Sakamoto; A Jacqueline Ryan; Natasha Kyprianou
Journal:  J Cell Biochem       Date:  2008-02-15       Impact factor: 4.429

7.  Inhibition of prolyl hydroxylase protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity: model for the potential involvement of the hypoxia-inducible factor pathway in Parkinson disease.

Authors:  Donna W Lee; Subramanian Rajagopalan; Ambreena Siddiq; Roberto Gwiazda; Lichuan Yang; M Flint Beal; Rajiv R Ratan; Julie K Andersen
Journal:  J Biol Chem       Date:  2009-08-13       Impact factor: 5.157

8.  Reactive oxygen species-generating mitochondrial DNA mutation up-regulates hypoxia-inducible factor-1alpha gene transcription via phosphatidylinositol 3-kinase-Akt/protein kinase C/histone deacetylase pathway.

Authors:  Nobuko Koshikawa; Jun-Ichi Hayashi; Akira Nakagawara; Keizo Takenaga
Journal:  J Biol Chem       Date:  2009-10-01       Impact factor: 5.157

Review 9.  Regulatory mechanism of HIF-1α and its role in liver diseases: a narrative review.

Authors:  Qingfei Chu; Xinyu Gu; Qiuxian Zheng; Haihong Zhu
Journal:  Ann Transl Med       Date:  2022-01

10.  The role of factor inhibiting HIF (FIH-1) in inhibiting HIF-1 transcriptional activity in glioblastoma multiforme.

Authors:  Enfeng Wang; Chunyang Zhang; Navatha Polavaram; Fengming Liu; Gang Wu; Mark A Schroeder; Julie S Lau; Debabrata Mukhopadhyay; Shi-Wen Jiang; Brian Patrick O'Neill; Kaustubh Datta; Jinping Li
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.